+1-626-295-2442 (Worldwide) 400-606-8865 (China)
Sign in Register
English

Global Antivenom Serum Market is Projected to Reach US$ 958 Mn by 2023

Author: QYResearch | Publish date: 2018-08-22 | Views: 62
New report published by QY Research which offers insights on the global Antivenom Serum market. The Antivenom Serum market has been experiencing steady growth graph since past years. During the 2018-2023 timeline, the global market for Antivenom Serum is expected to reflect a 1.1x increase in the revenue growth. In 2017 the global Antivenom Serum market was valued at US$ 828 Mn and by the end of the assessment year (2023), it is estimated to touch a value more than US$ 958 Mn growing at a value CAGR of 2.46% throughout the period of forecast.

image.png

Global Antivenom Serum Market: Market Driver and Restraint

Antivenom Serum is in used to treat certain venomous bites and stings. The global market of Antivenom Serum Industry is really scattered due to the wide application and consumption scale.


Global Antivenom Serum Market: Forecast by Type

This segment includes Polyvalent and Monovalent. Polyvalent segment is expected to remain dominant in the global Antivenom Serum market throughout the forecast period with a revenue share of Polyvalent in 2017. Polyvalent segment is expected to rank relatively high on the attractiveness index in the global Antivenom Serum market by 2023 end as well.


Global Antivenom Serum Market: Forecast by Application

Application segment consists of Hospitals, Retail Pharmacies and others. In 2017, the Hospitals segment was estimated to be valued at 5,576 Kilo Vials.


Global Antivenom Serum Market: Forecast by Region

Asia-Pacific, North America, Europe, Japan, Middle East and Africa are the six regions that are included in this report. Asia-Pacific is the dominant market in the global Antivenom Serum market in terms of sales. The Asia-Pacific Antivenom Serum market was estimated to be valued at 1769 Kilo Vials in 2017.


Global Antivenom Serum Market: Key Players

CSL Behring, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, and Serum Biotech, are the key vendors included in this report.


Click to view the full report TOC, figure and tables

https://www.qyresearch.com/index/detail/177587/global-antivenom-serum-market

CONTACT US
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
Our clients
<
4321
>
>